Time taken for approving drugs is similar in US to UKBMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7071.1504a (Published 14 December 1996) Cite this as: BMJ 1996;313:1504
The time taken to approve the marketing of new drugs in the United States is generally similar to that in Britain and faster than that in Germany and Japan, according to the Food and Drug Administration's retiring commissioner, Dr David Kessler.
Dr Kessler was one of the authors of a study of the marketing approval dates of 214 drugs introduced into the world market between January 1990 and December 1994 (JAMA 1996:276:1826-31). The study showed that the United States and Britain have similar patterns of drug availability, but the United States has several drugs that are not available in Britain which the Food and Drug Administration considers to have important public health benefits (table).
The study says that the association has streamlined its drug approval …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial